Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03821064 · ClinicalTrials.gov registry record · NA

Single-arm Phase II Study of NDURE for Patients With HNC

A NA study of Cancer of Head and Neck, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT03821064 is a NA study of Cancer of Head and Neck that has completed, run by Medical University of South Carolina. The registered enrollment target is 11 participants, below the 248-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03821064, a NA study of Cancer of Head and Neck, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate whether a new patient navigation intervention can decrease delays starting post-operative radiation therapy after surgery for white and African-American head and neck cancer patients.

Conditions Studied

Interventions

  • OTHER Patient Navigation

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2019-06-03
Est. Completion 2019-11-21
Phase NA

What the Registry Record Tells You About NCT03821064

The ClinicalTrials.gov registry entry for NCT03821064 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 248-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (96% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.

NCT03821064 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03821064 about?

NCT03821064 is a clinical study titled "Single-arm Phase II Study of NDURE for Patients With HNC". This study will evaluate whether a new patient navigation intervention can decrease delays starting post-operative radiation therapy after surgery for white and African-American head and neck cancer patients.

What is the current status of trial NCT03821064?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-06-03. Estimated completion is 2019-11-21.

What conditions does trial NCT03821064 study?

This clinical trial studies the following conditions: Cancer of Head and Neck.

What interventions are being tested in trial NCT03821064?

The interventions under investigation include: Patient Navigation (OTHER).

Who is sponsoring clinical trial NCT03821064?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03821064 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer of Head and Neck

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.